Edwards Lifesciences, based in Irvine, California, is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
Health Technology Wales (HTW) is a national body working to improve the quality of care in Wales. Our work focuses on the identification, appraisal and adoption of health technologies into the Welsh health and care setting. We cover all health technologies that are not medicines, such as medical devices, surgical procedures, psychological therapies, tele-monitoring or rehabilitation. We collaborate with partners across health, social care and the technology sectors to ensure a consistent approach.
China National Health Development Research Center (CNHDRC) is a national policy research and consultant institution under the leadership of National Health and Family Planning Commission of China (NHFPC). It was established in 1991 and previously known as China Health Economics Institute (CHEI). After being approved by the Chinese Staffing Committee and NHFPC it formally changed the name to the China National Health Development Research Center.
CADTH is an independent, not-for-profit organization responsible for providing Canada’s health care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs and medical devices in our health care system. Learn why we are a trusted pan-Canadian source of credible health care evidence.
Bayer is a life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are helping find solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Angelini is a Private Company established in Italy in the early 1900s.The Company has operations in 20 Countries and worldwide distribution, employs about 6000 people, with an annual turnover of more than 1.6 billion Euros.Angelini is an “integrated pharmaceutical company” with extensive R&D programs, world-class manufacturing and marketing of active ingredients, brand-name drugs, pharmaceutical equivalents and nutraceuticals. Angelini is committed to help patients in fighting illnesses with efforts in Mental health, Pain, Inflammation, Supportive/Palliative Oncologic Care, and Infectious Diseases.
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
The Department of Health Policy at London School of Economics and Political Science trains and inspires people passionate about health. We offer a range of executive MSc programmes in health policy and economics, taught by world-leading academics and experts. Our degrees are specially designed for health professionals looking to elevate their career and develop as health policy leaders. For more information, visit our website.
IQWiG is the German HTA Agency, established under the Health Care Reform 2004 as an institution of the Foundation for Quality and Efficiency in Health Care. IQWiG’s legal foundations and responsibilities are laid down in the German Social Code Book V. As an independent scientific institute, IQWiG examines the benefits and harms of medical interventions for patients. The institute produces independent, evidence-based HTA reports on:
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. The company was founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. To learn more, visit www.lilly.com.
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy and is focused on advancing neuroscience research programs in Alzheimer’s disease and dementia.
Bayer Vital GmbH distributes the drugs of the Consumer Health and Pharmaceuticals divisions as well as the veterinary medicines of the Animal Health business unit in Germany. More information about Bayer Vital GmbH can be found at: www.gesundheit.bayer.de
Kaiser Permanent is committed to helping shape the future of health care. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente provides high-quality, affordable health care services to improve the health of more that 12 million members and the communities we serve in eight states and the District of Columbia.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.
Health Economics and Health Technology Assessment (HEHTA) is a multi-disciplinary academic research group at the University of Glasgow. We are a fast growing and vibrant team of researchers, who are dedicated to delivering research that has direct impact on clinical practice, population health and health policies, both nationally and internationally. Our methodological expertise include economic evaluation alongside trials, decision analytic modelling, evidence synthesis, population health economics, precision medicine, global HTA, medical statistics and qualitative evaluations. We are also committed to delivering cutting-edge education for researchers and practitioners in a bid to forge successful careers in HTA.Our vision is to be the world-leading centre for research and education, working to improve health and well being through better decision-making.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Set up in 2009 at the Università Cattolica del Sacro Cuore (Rome campus) as a result of a scientific collaboration between the faculty of Economics and the faculty of Medicine and Surgery, ALTEMS operates within the field of Economics and Healthcare management and offers qualification-based training at various stages in the professional development of people employed in the field of private and public healthcare. The mission of ALTEMS, in which its fundamental purposes are stated, is “to plan, organise and deliver post-graduate and executive training programmes within the fields of economics and health care management.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi, Empowering Life
We are global leaders in health technology assessment. Leveraging the unique position within a Medical College, our experts develop insightful assessments based on your agency’s brief. We tailor reports on health economics, budgetary impact, statistical analyses and the safety and effectiveness of health technologies that meet your requirements.
The National institute for Health and Care Excellence (NICE) was set up in 1999 to reduce variation in the availability and quality of NHS treatments and care in England. Today it is responsible for developing national guidance, standards and information on providing high-quality health and social care, and preventing ill health. NICE guidance helps health, public health and social care professionals deliver the best possible care based on the best available evidence.
Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people’s lives. With challenges facing families and healthcare systems — such as rising costs, aging populations, and the burden of chronic disease — we are using the power of technology to take healthcare Further, Together.
Innovation and collaboration are central to who we are. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value — for healthcare systems, providers, and the people they serve. Learn more at Medtronic.com.
Healthcare Coverage Designed for Your Community, Accessible Across the Country
For more than 80 years, Blue Cross and Blue Shield (BCBS) companies have provided secure and stable healthcare coverage to people in communities across the country. BCBS grew out of a grassroots approach to a prepaid hospital plan in 1929. Today, the 36 independent and locally operated BCBS companies take what we learn from covering nearly 106 million people – one in three Americans – and use that knowledge to improve our healthcare system, and the health and wellness of our local communities.
Blue Cross Blue Shield Association is an association of independent Blue Cross and Blue Shield companies.
The German Society for Health Technology Assessment (HTA.de) is the only scientific HTA society in Germany, comprising members from Germany, Switzerland, Austria and Luxembourg. The Society supports the exchange of knowledge about the direct and indirect consequences of the application of medical technologies in health care. Development of methodology, organization of scientific workshops, advice to decision-makers and training and education included. Among others, HTA.de supports an Online HTA Course at the Technical University of Berlin. HTA.de is an official acknowledged non-profit-society.
Medlior Health Outcomes Research Ltd., is a boutique consultancy based out of Western Canada. Medlior offers a variety of research services, including medical writing, systematic literature reviews, HTA services, statistical analyses and Real World Data (RWD) analytics using Canada’s comprehensive health system data. Driven by scientific expertise and robust methodology, Medlior brings valuable insights to every research project.
Numerus is a statistical contract research organisation (CRO) with a proven track record in clinical trials, a specialised skillset for health technology assessment, and innovative capabilities in applying statistics and epidemiology to real world data.
Amaris Health Economics & Market Access is an international consulting company that provides searches which aim to ensure patients access to new and innovative health technologies. We support health policy decisions by proving the value of new medicines and medical devices. We gather, model, interpret and effectively communicate evidence in the most scientifically robust way.
IHS Markit offers solutions for corporate, government, and association clients in the healthcare and pharmaceutical industries optimize product and market portfolios, strategize for innovative products and processes, expand your global footprint and operate sustainably throughout the life cycle of a medical product.With unique data, analytics and tools, we help you monitor and quantify the global impact of the competitive pricing and reimbursement environment, market access and tendering strategies, disease trends and therapeutic breakthroughs, evolving healthcare budget and expenditures, and much more.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, our proprietary purpose-built asset which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 58,000 employees worldwide. Learn more at iqvia.com.
SBU evaluates methods used by medical and social services. SBU is an independent national authority, tasked by the Swedish government with assessing healthcare and social service interventions from a comprehensive perspective. SBU assessments are based on systematic reviews of published research, completed by analyses of economic, social, and ethical aspects. Our assessments are scientifically thorough and rigorous.
Parexel is focused on supporting the development of innovative new therapies to improve patient health. We do this through a suite of services that help life science and biopharmaceutical customers across the globe transform scientific discoveries into new treatments for patients. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do. For more information, visit our website and follow us on LinkedIn and Twitter. Parexel is a registered trademark of Parexel International Corporation. All other trademarks are the property of their respective owners.
Cambridge University Press is a not-for-profit publisher that dates from 1534. We are part of the University of Cambridge and our mission is to unlock people’s potential with the best learning and research solutions. Visit our stand to discuss publishing with us, browse our publications and get a 20% discount.
Synergus RWE develop and execute Market Access and RWE strategies for Western Europe. Our focus in RWE is the development of pan-European strategies and execution of studies in the Nordics. In market access our focus is medical devices, diagnostics and digital health solutions.
Evidence Partners is the world leader in software that makes the entire systematic review process faster, more transparent, and audit-ready. Now with a state-of-the-art artificial intelligence screening assistant, DistillerSR is used by leading research organizations, regulatory bodies, government agencies, and medical product companies to manage and deliver their reviews more efficiently and effectively. For more information, visit www.evidencepartners.com.
admedicum Business for Patients is a European expert group for patient engagement with industry. Early patient engagement can more accurately align the needs of patients with the products and services of companies to ensure sustainable value for both patients and enterprises. We help companies to add value by involving the right patient partners in regard of e.g. clinical trial design, quality of life data generation (patient reported outcomes/real world evidence) or recruitment/retention. We are unique in combining a deep understanding of regulatory and HTA authorities’ expectations in regard of patient relevance data of new treatment applications (market/patient access) with high credibility and broad networks among patient organizations European-wide. We know what to do and how to do R&D together with patients.
GalbraithWight; a global strategic market access consultancy with teams in the US & Europe, and 20+ years successful experience.
We focus specifically on the needs of innovative Biotech companies from Phase Ib/IIa. We have developed BIO-MAP; our comprehensive all-in-one package of everything a Biotech company needs to ensure robust preparation to meet Payer requirements in the US and Europe.
Pharmerit International partners with pharmaceutical, biotechnology and medical device organizations to conduct Health Economics and Outcomes Research (HEOR) and strategic market access worldwide. We use our collective experience and creativity to address the unique need of every research question, implementing innovative, multidimensional solutions to uncover and communicate the value of healthcare innovations. Pharmerit has offices in Bethesda, Boston, Berlin, Mumbai, New York, Oxford, Rotterdam, Shanghai and York.